Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $49,013 | 22 | 47.6% |
| Honoraria | $34,720 | 20 | 33.7% |
| Travel and Lodging | $14,634 | 29 | 14.2% |
| Food and Beverage | $3,696 | 61 | 3.6% |
| Consulting Fee | $914.75 | 2 | 0.9% |
| Gift | $19.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $90,950 | 104 | $0 (2023) |
| Amgen Inc. | $11,125 | 17 | $0 (2024) |
| Alcon Laboratories Inc | $277.68 | 2 | $0 (2018) |
| MERZ NORTH AMERICA, INC. | $164.54 | 3 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $146.55 | 1 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2021) |
| GLAUKOS CORPORATION | $99.66 | 1 | $0 (2022) |
| Mallinckrodt LLC | $60.22 | 3 | $0 (2017) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
| Shire North American Group Inc | $16.96 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,422 | 20 | Amgen Inc. ($11,125) |
| 2023 | $30,436 | 31 | Horizon Therapeutics plc ($30,436) |
| 2022 | $35,149 | 39 | Horizon Therapeutics plc ($35,050) |
| 2021 | $23,981 | 25 | Horizon Therapeutics plc ($23,856) |
| 2020 | $1,504 | 6 | Horizon Therapeutics plc ($1,484) |
| 2019 | $124.84 | 6 | Horizon Therapeutics plc ($124.84) |
| 2018 | $131.58 | 1 | Alcon Laboratories Inc ($131.58) |
| 2017 | $248.70 | 7 | Alcon Laboratories Inc ($146.10) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/09/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: Dermatology | ||||||
| 08/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/05/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $146.55 | General |
| 06/26/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $637.50 | General |
| 05/29/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/13/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| 05/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,975.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Travel and Lodging | In-kind items and services | $1,174.60 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $109.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/16/2024 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $116.37 | General |
| 03/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/27/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $136.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/16/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/16/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $2,550.00 | General |
| Category: TEPEZZA | ||||||
| 11/16/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | In-kind items and services | $754.27 | General |
| Category: TEPEZZA | ||||||
| 11/16/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $107.23 | General |
| Category: TEPEZZA | ||||||
| 11/14/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $5.11 | General |
| Category: TEPEZZA | ||||||
| 10/23/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 719 | 793 | $337,881 | $104,427 |
| 2022 | 15 | 757 | 843 | $342,288 | $104,035 |
| 2021 | 15 | 743 | 848 | $257,047 | $88,262 |
| 2020 | 13 | 705 | 836 | $236,913 | $87,213 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 36 | 36 | $70,808 | $21,934 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 147 | 147 | $47,534 | $16,105 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 171 | $24,768 | $10,340 | 41.7% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 15 | 15 | $27,962 | $9,496 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 105 | $22,266 | $9,113 | 40.9% |
| 68720 | Creation of drainage tract from tear sac to nasal cavity | Facility | 2023 | 12 | 12 | $34,438 | $7,472 | 21.7% |
| 67903 | Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | Facility | 2023 | 14 | 16 | $20,920 | $7,072 | 33.8% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 38 | 46 | $22,997 | $5,717 | 24.9% |
| 67924 | Extensive repair of turning-inward eyelid defect | Facility | 2023 | 11 | 11 | $12,924 | $3,755 | 29.1% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 15 | 15 | $8,520 | $2,786 | 32.7% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2023 | 12 | 12 | $14,283 | $2,745 | 19.2% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 94 | 97 | $8,949 | $2,235 | 25.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $6,330 | $1,954 | 30.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 48 | 49 | $4,233 | $1,883 | 44.5% |
| 68815 | Probing of nasal tear duct with insertion of tube or stent | Facility | 2023 | 17 | 18 | $10,184 | $1,585 | 15.6% |
| 92285 | Photography of content of eyes | Office | 2023 | 14 | 14 | $766.08 | $235.34 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 181 | 181 | $57,015 | $20,503 | 36.0% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 27 | 27 | $53,440 | $16,348 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 185 | $26,640 | $11,075 | 41.6% |
| 68720 | Creation of drainage tract from tear sac to nasal cavity | Facility | 2022 | 14 | 16 | $45,458 | $10,182 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 102 | $21,424 | $8,946 | 41.8% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Facility | 2022 | 15 | 18 | $31,230 | $7,083 | 22.7% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2022 | 11 | 11 | $20,336 | $7,066 | 34.7% |
| 68840 | Probing of nasal tear duct | Office | 2022 | 44 | 45 | $22,345 | $5,286 | 23.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 53 | 53 | $10,918 | $4,096 | 37.5% |
About Dr. Rakesh Patel, M.D
Dr. Rakesh Patel, M.D is a Ophthalmology healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1467614792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rakesh Patel, M.D has received a total of $102,997 in payments from pharmaceutical and medical device companies, with $11,422 received in 2024. These payments were reported across 135 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($49,013).
As a Medicare-enrolled provider, Patel has provided services to 2,924 Medicare beneficiaries, totaling 3,320 services with total Medicare billing of $383,938. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery
- Location Columbia, SC
- Active Since 06/27/2008
- Last Updated 08/11/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1467614792
Products in Payments
- TEPEZZA (Drug) $90,761
- TEPEZZA (Biological) $7,938
- AcrySof (Device) $277.68
- rhopressa (Drug) $125.00
- KXL SYSTEM (Device) $99.66
- ACTHAR (Biological) $60.22
- Xeomin (Biological) $34.04
- None Specified (Medical Supply) $19.40
- XIIDRA (Drug) $16.96
- OXAYDO (Drug) $11.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Columbia
Dr. Matthew Clary, M.d, M.D
Ophthalmology — Payments: $106,296
Dr. Jella An, M.d, M.D
Ophthalmology — Payments: $105,959
Sandra Johnson, M.d, M.D
Ophthalmology — Payments: $24,249
Willard Harms, Md, MD
Ophthalmology — Payments: $23,434
Frederick Fraunfelder, M.d, M.D
Ophthalmology — Payments: $12,972
John Mccann, Md Phd, MD PHD
Ophthalmology — Payments: $12,220